Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
Clinical trial NCT01902966 · TERMINATED
Trial details
- NCT number
- NCT01902966
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-11
- Primary completion
- 2020-08-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.